Supplementary Table S5.
Mean Relative Abundances (%) of Genera Identified on Differential Analysis Comparing Bacterial Communities in the Samples of HCs Versus in Patients with MF/SS—Sidak Method for Pairwise Comparisons: HC Versus MF/SS, Organized by Clinical Stage
| Group 1 | Group 2 | Mean Difference | P-Value |
|---|---|---|---|
| Alishewanella | |||
| HC | MF/SS, IA‒IIA | 0.114 | 0.013 |
| HC | MF/SS, IIB‒IVB | 0.074 | 0.220 |
| MF/SS, IA‒IIB | MF/SS, IIB‒IVB | ‒0.040 | 0.663 |
| Allorhizobium-Neorhizobium-Pararhizobium-Rhizobium | |||
| HC | MF/SS, IA‒IIA | 0.152 | 0.001 |
| HC | MF/SS, IIB‒IVB | 0.089 | 0.130 |
| MF/SS, IA‒IIB | MF/SS, IIB‒IVB | ‒0.063 | 0.350 |
| Catenococcus | |||
| HC | MF/SS, IA‒IIA | 0.173 | 0.016 |
| HC | MF/SS, IIB‒IVB | 0.053 | 0.800 |
| MF/SS, IA‒IIB | MF/SS, IIB‒IVB | ‒0.120 | 0.148 |
| Marinobacter | |||
| HC | MF/SS, IA‒IIA | 0.106 | 0.044 |
| HC | MF/SS, IIB‒IVB | 0.081 | 0.225 |
| MF/SS, IA‒IIB | MF/SS, IIB‒IVB | ‒0.026 | 0.912 |
| Paracoccus | |||
| HC | MF/SS, IA‒IIA | 0.159 | 0.043 |
| HC | MF/SS, IIB‒IVB | 0.085 | 0.512 |
| MF/SS, IA‒IIB | MF/SS, IIB‒IVB | ‒0.744 | 0.581 |
| Roseomonas | |||
| HC | MF/SS, IA‒IIA | 0.159 | 0.043 |
| HC | MF/SS, IIB‒IVB | 0.085 | 0.512 |
| MF/SS, IA‒IIB | MF/SS, IIB‒IVB | ‒0.744 | 0.581 |
| Vibrio | |||
| HC | MF/SS, IA‒IIA | 0.184 | 0.011 |
| HC | MF/SS, IIB‒IVB | 0.207 | 0.007 |
| MF/SS, IA‒IIB | MF/SS, IIB‒IVB | 0.024 | 0.974 |
Abbreviations: HC, healthy control; MF, mycosis fungoides; SS, Sézary syndrome.